You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (1) |
Back to Search
A clinical trial of propolis supplementation on type II diabetic patients treated with gliclazide and metformin
- In: Posters
- At: Dublin (Ireland) (2013)
- Type: Poster
- By: HASHEM, Noha (Future University, Clinical Pharmacy and Pharmacy Practice, Cairo, Egypt)
- Co-author(s): Elshamy, Abd El-Hameed (Ain Shams University, Cairo, Egypt)
Maher, Maram (Ain Shams University, Cairo, Egypt)
Badary, Osama (Ain Shams University, Cairo, Egypt) - Abstract:
Background
: Propolis is a natural product derived from plant resins and exudates and has been proven to have various biological activities.
Aim
: This study investigates the efficacy and safety of propolis in type 2 diabetic patients treated with gliclazide and metformin.
Methods
: This is a prospective, pilot, randomized, controlled, open-label, .. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026